These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11119945)

  • 21. High dose steroid regime: a tool for reducing organ rejection.
    Jawad F; Naqvi A; Rizvi A
    Transplant Proc; 2001 Aug; 33(5):2786. PubMed ID: 11498160
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
    Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H
    Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
    [No Abstract]   [Full Text] [Related]  

  • 23. Early fluctuation in cyclosporine A trough levels affects long-term outcome of kidney transplants.
    Inoue S; Beck Y; Nagao T; Uchida H
    Transplant Proc; 1994 Oct; 26(5):2571-3. PubMed ID: 7940795
    [No Abstract]   [Full Text] [Related]  

  • 24. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 25. Results of various immunosuppressive regimens at our transplantation center.
    Karakayali H; Moray G; Demirağ A; Akkoç H; Haberal M
    Transplant Proc; 1998 Nov; 30(7):3101-2. PubMed ID: 9838368
    [No Abstract]   [Full Text] [Related]  

  • 26. Causes of long-term renal allograft failure: no chronic rejection at three years.
    Shen GK; Isenberg AL; Singh TP; Hahn A; Conti DJ
    Transplant Proc; 1998 Jun; 30(4):1205-6. PubMed ID: 9636489
    [No Abstract]   [Full Text] [Related]  

  • 27. Posttransplant diabetes mellitus in live-related renal transplantation.
    Jawad F; Rizvi SA
    Transplant Proc; 2000 Nov; 32(7):1888. PubMed ID: 11119986
    [No Abstract]   [Full Text] [Related]  

  • 28. Outcome of renal transplantation under cyclosporine immunosuppression in patients with lupus nephritis.
    Cobankiat J; Vathsala A; Lu YM; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1826-7. PubMed ID: 11119955
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of vesicoureteral reflux on graft survival in paediatric kidney transplants.
    Fontana I; Ginevri F; Arcuri V; Basile G; Nocera A; Beatini M; Barocci S; Tommasi GV; Bonato L; Casolino V; Valente R; Gusmano R; Valente U
    Transplant Proc; 1998 Aug; 30(5):2000-1. PubMed ID: 9723368
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of donor age on kidney graft function and on histopathological findings.
    Isoniemi H; von Willebrand E; Krogerus L; Taskinen E; Ahonen J; Häyry P
    Transplant Proc; 1992 Feb; 24(1):328-9. PubMed ID: 1539296
    [No Abstract]   [Full Text] [Related]  

  • 31. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
    Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA
    Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of long-term results in kidney transplantation performed using a rejection-free protocol with cyclosporine and thoracic duct drainage.
    Kinukawa T; Ono Y; Takeuchi N; Hattori R; Ohshima S
    Transplant Proc; 1997; 29(1-2):946-7. PubMed ID: 9123600
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduction of immunosuppressive therapy after renal transplantation: a randomized study.
    Heering P; Westhoff A; Ivens K; Kutkuhn B; Grabensee B
    Transplant Proc; 1994 Oct; 26(5):2530-2. PubMed ID: 7940778
    [No Abstract]   [Full Text] [Related]  

  • 34. First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation.
    Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
    Transplant Proc; 1992 Oct; 24(5):2241-2. PubMed ID: 1413040
    [No Abstract]   [Full Text] [Related]  

  • 35. Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.
    Shaffer D; Madras PN; Conway P; Davis C; Simpson MA; Monaco AP
    Transplant Proc; 1997; 29(1-2):342-3. PubMed ID: 9123031
    [No Abstract]   [Full Text] [Related]  

  • 36. Early experience with simulect (basiliximab) induction in living donor renal allografting in India.
    Siwach V; Dhanda R; Aggarwal B; Singh B; Jain PK; Sarin PK
    Transplant Proc; 2003 Feb; 35(1):196-7. PubMed ID: 12591364
    [No Abstract]   [Full Text] [Related]  

  • 37. Improved success of pediatric renal transplantation.
    Seki T; Takeuchi I; Tanda K; Chikaraishi T; Kanagawa K; Nonomura K; Togashi M; Koyanagi T
    Transplant Proc; 1994 Aug; 26(4):2067-8. PubMed ID: 8066672
    [No Abstract]   [Full Text] [Related]  

  • 38. Living donor renal transplantation--experience with 50 patients in 5 years.
    Wolters HH; Vowinkel T; Brockmann J; Palmes D; Heidenreich S; Dietl KH
    Transplant Proc; 2002 Sep; 34(6):2216. PubMed ID: 12270370
    [No Abstract]   [Full Text] [Related]  

  • 39. Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy.
    Gregory CR; Kyles AE; Bernsteen L; Mehl M
    Vet Surg; 2006 Feb; 35(2):105-12. PubMed ID: 16472290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined liver-kidney transplantation: long-term follow-up in 18 patients.
    Lang M; Kahl A; Bechstein WO; Neumann U; Settmacher U; Frei U; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):1865-7. PubMed ID: 9723313
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.